[Benign infantile mitochondrial myopathy caused by reversible cytochrome c oxidase deficiency].
A 2-month-old girl had generalized weakness, profound muscular hypotonia, hepatomegaly and severe lactic acidosis. She needed ventilatory support. Muscle specimen taken at 2 months showed ragged-red fibers, abnormal mitochondria, and reduced cytochrome c oxidase (CCO) staining Biochemical analysis showed CCO activity to be reduced to about 16% of the normal mean. She received carnitine and coenzyme Q10 supplementation from the age of 3 months and abnormal blood lactate values declined to near normal values during the first three weeks. Gradually her condition started to improved: she held her head at 9 months, and walked alone at 15 months. The second biopsy specimen at 3 years and 8 months showed almost normal CCO staining and she was free of clinical signs. This case is an example of a rare benign infantile mitochondrial myopathy caused by CCO deficiency. Early diagnosis is crucial to provide intensive treatment until spontaneous clinical improvement appears. We concluded that carnitine and coenzyme Q10 supplementation was a useful treatment for clinical improvement in patients with a benign infantile mitochondrial myopathy caused by CCO deficiency.
Wada
H
H
Department of Pediatrics, Kobe University School of Medicine.
Nishio
H
H
Nagaki
S
S
Yanagawa
H
H
Imamura
A
A
Yokoyama
S
S
Sano
T
T
Woo
M
M
Matsuo
M
M
Itoh
H
H
Nakamura
H
H
D002331:Carnitine / Q000008:administration & dosage; D030401:Cytochrome-c Oxidase Deficiency; D005260:Female; D006801:Humans; D007223:Infant; D017240:Mitochondrial Myopathies / Q000188:drug therapy / Q000209:etiology*; D014451:Ubiquinone / Q000008:administration & dosage
D014451:Ubiquinone; D002331:Carnitine